Injection, kanamycin sulfate, up to 75 mg
HCPCS code
Name of the Procedure:
Injection, Kanamycin Sulfate, up to 75 mg
- Common Names: Kanamycin injection
- Medical Term: Intramuscular (IM) or Intravenous (IV) administration of Kanamycin Sulfate
Summary
An injection of kanamycin sulfate delivers an antibiotic used to treat severe bacterial infections. Administered by healthcare professionals, it helps combat bacteria that are not responding to other antibiotics.
Purpose
- Medical Conditions: Used to treat severe infections caused by bacteria, such as tuberculosis or certain hospital-acquired infections.
- Goals: To eliminate bacterial infections, reduce symptoms, and prevent the spread of infection, ultimately leading to patient recovery.
Indications
- Symptoms/Conditions: Severe bacterial infections, particularly those resistant to other antibiotics.
- Patient Criteria: Typically administered to patients with confirmed bacterial infections who have not responded to other treatments.
Preparation
- Patient Instructions: No major preparation required, but patients should inform their healthcare provider of all medications they are currently taking and any allergies.
- Diagnostic Tests: Blood tests or cultures to identify the specific bacteria causing the infection.
Procedure Description
- Preparation: The healthcare provider will prepare the prescribed dose of kanamycin sulfate, up to 75 mg.
- Administration:
- Intramuscular (IM): The injection site (typically arm, thigh, or buttocks) is cleaned with antiseptic.
- Intravenous (IV): An IV line is inserted into a vein, usually in the arm.
- Injection: The kanamycin sulfate is then injected into the chosen site.
- Monitoring: Patients are monitored for any immediate adverse reactions after the injection.
- Tools: Sterile syringe, antiseptic swabs, kanamycin sulfate solution.
- Anesthesia/Sedation: Not typically required, but local anesthesia may be used for patient comfort.
Duration
The procedure generally takes a few minutes, though monitoring will take additional time.
Setting
Typically performed in a hospital, outpatient clinic, or other medical facilities equipped for sterile injections.
Personnel
- Healthcare Professionals: Nurses, physicians, or other trained medical staff administer the injection and monitor the patient.
Risks and Complications
- Common Risks: Localized pain or swelling at the injection site, nausea.
- Rare Risks: Allergic reactions, kidney toxicity, hearing loss, or ototoxicity.
- Complication Management: Immediate medical attention for severe adverse reactions, potential discontinuation of the drug, and alternative treatments.
Benefits
- Expected Benefits: Effective eradication of severe bacterial infections.
- Realization of Benefits: Typically within a few days to a week, depending on the infection severity and patient response.
Recovery
- Post-Procedure Care: Monitor for signs of allergic reactions or side effects. Patients should report any unusual symptoms.
- Recovery Time: Varies based on infection severity but generally improves significantly within a few days to weeks.
- Restrictions/Follow-Up: Follow-up appointments may be necessary to assess the efficacy of the treatment and manage any side effects.
Alternatives
- Treatment Options: Other antibiotics, oral medications, or different routes of administration.
- Pros and Cons:
- Pros of Kanamycin: Effective against resistant bacteria.
- Cons: Potential for severe side effects like nephrotoxicity and ototoxicity.
Patient Experience
During the injection, patients may feel a brief sting or pinch. Discomfort at the injection site may occur but usually subsides quickly. Post-injection, patients should experience a reduction in infection symptoms. Pain management and comfort measures, like applying ice to the injection site, may be recommended.